Floatz logo

Pregabalin

Postherpetic Neuralgia

Neurodawn Pharmaceutical Co., Ltd.Small moleculePhase 4 / ApprovedActive
BBB
76/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
73/ 100
Competitive Position
81/ 100

Competitive context

17 Active assets in the Postherpetic Neuralgia cohort.

Asset / SponsorPhaseRating
LIDOCAINE
Seoul National University Hospital
Phase 4BBB
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)-
University of Medicine and Pharmacy at Ho Chi Minh City
Phase 4BBB
Capsaicin
Astellas Pharma Europe Ltd.
Phase 4BBB
(±)-TRAMADOL
Astellas Pharma Inc
Phase 4BB
Crisugabalin
Haisco Pharmaceutical Group Co., Ltd.
Phase 3BB

View all 50 →

Same molecule, other indications

Pregabalin is also rated in:

focal epilepsyDormant
A
Indicative ·
82 / 100
View asset →
peripheral neuropathyDormant
A
Indicative ·
82 / 100
View asset →
Depressive Disorder, MajorDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →